Product Information
PLAVIX 75 MG TABLET is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $8.1990 per EA under NDC 00024117190. Its NADAC has been published 298 times since Oct 14, 2020.
The High Outlier badge above means this manufacturer's average price in the clopidogrel market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024117190
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOPIDOGREL BISULFATEApproval Type
New Drug (NDA)
FDA Application
NDA020839On Market Since
11/17/1997
Pharmacological Classes
Price Statistics
The NADAC for PLAVIX 75 MG TABLET has been published 298 times since Oct 14, 2020, and over the history we have for it it has risen 32.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1990 per EA |
|---|---|
| All-time high | $8.2182 (May 13, 2026) |
| All-time low | $6.1858 (Oct 14, 2020) |
| 52-week high | $8.2182 |
| 52-week low | $8.0284 |
| Median price | $7.5551 |
| Average price | $7.5045 |
| Largest weekly change | +5.5% (Jan 12, 2022) |
| Weeks tracked | 298 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PLAVIX 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PLAVIX 75 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $8.1990 per EA (NDC 00024117190), effective Jun 24, 2026.
How has the price of PLAVIX 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for PLAVIX 75 MG TABLET has risen 32.5%. It has been tracked across 298 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for PLAVIX 75 MG TABLET?
Since Oct 14, 2020, the NADAC for PLAVIX 75 MG TABLET has ranged from a low of $6.1858 (Oct 14, 2020) to a high of $8.2182 (May 13, 2026), with a median of $7.5551 per EA.
Are there cheaper alternatives to PLAVIX 75 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CLOPIDOGREL 75 MG TABLET, is $0.0636 per EA — about 99% below PLAVIX 75 MG TABLET.
Who manufactures PLAVIX 75 MG TABLET?
PLAVIX 75 MG TABLET (NDC 00024117190) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification